Matches in Wikidata for { <http://www.wikidata.org/entity/Q64111915> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q64111915 description "article scientifique publié en 2004" @default.
- Q64111915 description "article" @default.
- Q64111915 description "im Juli 2004 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64111915 description "wetenschappelijk artikel" @default.
- Q64111915 description "наукова стаття, опублікована в липні 2004" @default.
- Q64111915 name "Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization f" @default.
- Q64111915 name "Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization f" @default.
- Q64111915 type Item @default.
- Q64111915 label "Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization f" @default.
- Q64111915 label "Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization f" @default.
- Q64111915 prefLabel "Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization f" @default.
- Q64111915 prefLabel "Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization f" @default.
- Q64111915 P1433 Q64111915-169DABC8-E216-4428-8859-CBB2F93F2799 @default.
- Q64111915 P1476 Q64111915-806A0FE1-7AAB-4C98-884C-039395326AAB @default.
- Q64111915 P2093 Q64111915-0090938C-C7D6-48C1-A2CF-F1853B64F2DF @default.
- Q64111915 P2093 Q64111915-144E804F-C4F7-40C2-A99B-542FD3FA6207 @default.
- Q64111915 P2093 Q64111915-283C5565-DBD0-45E9-A316-F6E6ACF403C4 @default.
- Q64111915 P2093 Q64111915-524E685E-EFFE-44B6-89E9-9AAB4E813DFE @default.
- Q64111915 P2093 Q64111915-578972BC-5F1B-4F5F-B6AE-0E00237AB2CA @default.
- Q64111915 P2093 Q64111915-6C782DDC-3E7A-46B5-9814-F4D1993D5165 @default.
- Q64111915 P2093 Q64111915-900005D6-9256-4491-8BCA-667731216AC9 @default.
- Q64111915 P2093 Q64111915-AA2398D9-2B87-4D82-9B15-6980636FCEFC @default.
- Q64111915 P2093 Q64111915-D95E93B8-FC9A-40E5-BC5B-B20595102443 @default.
- Q64111915 P2093 Q64111915-EB02F5F7-55C2-41B6-A9FF-B66B7025E3F0 @default.
- Q64111915 P304 Q64111915-DED91A64-7FA9-4D6B-9592-AE1FCD899249 @default.
- Q64111915 P31 Q64111915-B72F8654-86D0-48A0-BED7-765F3D9EC455 @default.
- Q64111915 P356 Q64111915-72DD9160-41EB-44F1-A777-31F504B25F7F @default.
- Q64111915 P407 Q64111915-A1F00180-9B79-4F54-88CB-024A979FACA1 @default.
- Q64111915 P433 Q64111915-C871DDAF-24FD-4110-9B9C-089BE3A1BF06 @default.
- Q64111915 P478 Q64111915-E286CA15-8AAA-4850-A0F4-1B1DB52B9602 @default.
- Q64111915 P50 Q64111915-6DC75A76-9A30-41F8-BD13-7EBDAC97D7D3 @default.
- Q64111915 P50 Q64111915-757060D8-52B6-40B9-9303-CCC40041F3CE @default.
- Q64111915 P577 Q64111915-7228F6FD-9E8B-414C-B646-B5D385DA03DF @default.
- Q64111915 P698 Q64111915-54F3CC1A-603F-48EB-813F-AF28CFD5F081 @default.
- Q64111915 P921 Q64111915-22FF1ACB-FD89-4F5F-A025-EAA3C86280C3 @default.
- Q64111915 P921 Q64111915-2D0D7071-DBC0-4E77-A2EA-A78B5BABEEC9 @default.
- Q64111915 P921 Q64111915-9D8DBFD8-1DF3-4E3E-AD81-FA74AF2D6009 @default.
- Q64111915 P921 Q64111915-E6434221-B890-4488-A877-50468B69BE14 @default.
- Q64111915 P921 Q64111915-FAB89BEC-CBA4-4D7B-8866-345C151D89F8 @default.
- Q64111915 P356 JCO.2004.02.037 @default.
- Q64111915 P698 15226325 @default.
- Q64111915 P1433 Q400292 @default.
- Q64111915 P1476 "Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study" @default.
- Q64111915 P2093 "Andrew Bottomley" @default.
- Q64111915 P2093 "Corneel Coens" @default.
- Q64111915 P2093 "European Organization for Research and Treatment of Cancer Breast Cancer Group" @default.
- Q64111915 P2093 "Fabio Efficace" @default.
- Q64111915 P2093 "Hilary Allan Calvert" @default.
- Q64111915 P2093 "Martine Piccart" @default.
- Q64111915 P2093 "Pierre Fargeot" @default.
- Q64111915 P2093 "Robert E Coleman" @default.
- Q64111915 P2093 "Tanja Cufer" @default.
- Q64111915 P2093 "Teresa Gamucci" @default.
- Q64111915 P304 "2576-2586" @default.
- Q64111915 P31 Q13442814 @default.
- Q64111915 P356 "10.1200/JCO.2004.02.037" @default.
- Q64111915 P407 Q1860 @default.
- Q64111915 P433 "13" @default.
- Q64111915 P478 "22" @default.
- Q64111915 P50 Q47067174 @default.
- Q64111915 P50 Q60658485 @default.
- Q64111915 P577 "2004-07-01T00:00:00Z" @default.
- Q64111915 P698 "15226325" @default.
- Q64111915 P921 Q12859063 @default.
- Q64111915 P921 Q1436668 @default.
- Q64111915 P921 Q18936 @default.
- Q64111915 P921 Q423762 @default.
- Q64111915 P921 Q974135 @default.